# NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
> **ANDA215002** · Abbreviated New Drug Application (Generic) · Sponsor: ALVOGEN · Approved 2022-07-20
## Drug
- **FDA Application Number:** ANDA215002
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
- **Generic name:** Nitrofurantoin
- **Active ingredients:** NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ALVOGEN
- **First approval:** 2022-07-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215002)
---
*MORVS · CC0 1.0*